Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/215703
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Sources, production, and clinical treatments of milk fat globule membrane for infant nutrition and well-being

AutorFontecha, F. Javier CSIC ORCID ; Brink, Lauren; Wu, Steven; Pouliot, Yves; Visioli, Francesco; Jiménez-Flores, Rafael
Palabras claveMilk fat globule membrane
Polar lipid composition
Sources
Production
Clinical studies
Infant nutrition
Infant formula
Fecha de publicación30-may-2020
EditorMultidisciplinary Digital Publishing Institute
CitaciónNutrients 12(6): 1607 (2020)
ResumenResearch on milk fat globule membrane (MFGM) is gaining traction. The interest is two-fold; on the one hand, it is a unique trilayer structure with specific secretory function. On the other hand, it is the basis for ingredients with the presence of phospho- and sphingolipids and glycoproteins, which are being used as food ingredients with valuable functionality, in particular, for use as a supplement in infant nutrition. This last application is at the center of this Review, which aims to contribute to understanding MFGM’s function in the proper development of immunity, cognition, and intestinal trophism, in addition to other potential effects such as prevention of diseases including cardiovascular disease, impaired bone turnover and inflammation, skin conditions, and infections as well as age-associated cognitive decline and muscle loss. The phospholipid composition of MFGM from bovine milk is quite like human milk and, although there are some differences due to dairy processing, these do not result in a chemical change. The MFGM ingredients, as used to improve the formulation in different clinical studies, have indeed increased the presence of phospholipids, sphingolipids, glycolipids, and glycoproteins with the resulting benefits of different outcomes (especially immune and cognitive outcomes) with no reported adverse effects. Nevertheless, the precise mechanism(s) of action of MFGM remain to be elucidated and further basic investigation is warranted.
DescripciónThis article belongs to the Special Issue Breastmilk as a Model: Efforts to Improve Infant Formulae for Term Infants.
Versión del editorhttps://doi.org/10.3390/nu12061607
URIhttp://hdl.handle.net/10261/215703
DOI10.3390/nu12061607
ISSN2072-6643
E-ISSN2072-6643
Aparece en las colecciones: (CIAL) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Sources_Fontecha_Art2020.pdf2,7 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

32
checked on 01-abr-2024

SCOPUSTM   
Citations

78
checked on 23-abr-2024

WEB OF SCIENCETM
Citations

58
checked on 23-feb-2024

Page view(s)

129
checked on 23-abr-2024

Download(s)

203
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons